Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Alcon

Status: Completed

Conditions: Dry Eye

Treatments: Other: Systane® Ultra

Study type: Interventional

Funder types: Industry

Identifiers

NCT00946777

SMA-09-04

Details and patient eligibility

About

The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.

Enrollment: 19 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must have moderate corneal staining and exhibit a need to use artificial tears.

Exclusion criteria

• Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

19 participants in 1 patient group

Systane® Ultra

Experimental group

Treatment:

Other: Systane® Ultra